Contact Us

Alison Hey-Cunningham +61 2 9515 6651    


Centre of Research Excellence in Pulmonary Fibrosis
Respiratory Medicine and Sleep Unit
Level 11, Royal Prince Alfred Hospital
Camperdown NSW 2050



Online Enquiry

* Required fields

News and Media

News from 2021

Congratulations to Dr Gang Liu from the Centenary Institute and UTS for being awarded the inaugural CREATE Hope Scientific Fellowship in Pulmonary Fibrosis, funded by Lung Foundation Australia. Gang's project is "Extracellular matrix proteins regulate inflammation and fibrosis in idiopathic pulmonary fibrosis".

Global Health Talks will launch on October 1st 2021. Ahead of the launch of the new global health talk show, the first talk on a new global network on pulmonary fibrosis research, is timed to coincide with Pulmonary Fibrosis Awareness Month in September.

Host Mike Lesner, speaks with Dana Ball the Executive Director at Three Lakes Foundation, Mark Brooke the CEO at Lung Foundation Australia  and Associate Professor Tamera Corte, the Chief Investigator at the CRE in Pulmonary Fibrosis.


Congratulations to Dr Yet Khor for her success with an emerging leadership grant in the NHMRC Investigator Grants announced in September: "Interstitial lung disease: Improving patient outcomes through risk prediction and disease burden management". A major career milestone for Yet.

The August edition of the Australian Health Journal is featuring the global collaboration in Pulmonary Fibrosis research between Three Lakes Foundation, Lung Foundation Australia and Centre of Research Excellence in Pulmonary Fibrosis. Please click here to read the story and access the video.

A full time Level B Research Fellow position in Prof Anne Holland's group at Monash University The Alfred Hospital is currently being advertised. It would suit a clinical researcher, and will be focused on ILD.

Three Lakes Foundation announced in August that it is partnering with Lung Foundation Australia, the Centre of Research Excellence in Pulmonary Fibrosis and an Australian philanthropist with a personal connection to the rare disease to build a global network for research in pulmonary fibrosis. This global collaboration is focused on enabling the groups to leverage expertise, resources and knowledge to accelerate diagnosis, treatment and delivery of life-saving therapies for PF. “By joining forces, we will drive global awareness of PF and spur innovative solutions for people with PF,”  Principal Investigator  A/Prof Tamera Corte.

Read full detail about this exciting announcement here.


Congratulations to CREATE prize winners at the Australian Rare Lung Disease Conference! Yet Khor for best poster, John Mackintosh for best clinical and Tylah Miles for best abstract from a CREATE Fellow. Go Centre of Research Excellence in Pulmonary Fibrosis team! Thank you Nicole Goh and committee, Lung Foundation Australia and The Thoracic Society of Australia and New Zealand (TSANZ) for a highly successful event.


Congratulations to Dr Britt Clynick from University of Western Australia for being awarded best abstract submitted by a CREATE Fellow for her talk for the TSANZSRS meeting in May "A Unique Biomarker Signature for Progressive Idiopathic Pulmonary Fibrosis" 


We congratulate Dr Mariana Hoffman Barbosa, CREATE Fellow from Monash University and Alfred Health for receiving the early-career TSANZ Janet Elder Travel Award for her research, “Pulmonary rehabilitation for interstitial lung disease: evidence into practice?” 

2021 PACT Grant-in-Aid

Congratulations to CREATE Fellow Dr Yet Hong Khor from Austin Health and Christopher Ryerson from University of British Columbia for being awarded the PACT Grant-in-Aid, supported by Lung Foundation Australia and CRE-Pulmonary Fibrosis, for their research "Understanding overnight oximetry in fibrotic interstitial lung disease."

Prestigious TSANZ Society medal awarded to Professor Anne Holland

Professor Anne Holland in clinic
Congratulations to  Professor Anne Holland, who has been awarded the prestigious  Thoracic Society of Australia and New Zealand (TSANZ) Society Medal!  

The Society Medal was conceived as an acknowledgement of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy, and first awarded in 1992. 

Professor Holland is Professor of Physiotherapy at Monash University and Alfred Health in Melbourne, and a National Health and Medical Research Council (NHMRC) Leadership Fellow. 

Anne’s research aims to improve the lives of people with chronic lung disease using novel non-drug treatments. She developed a widely recognised home-based pulmonary rehabilitation model that improves access to effective care for people with COPD. Her model was recently included in NHMRC’s '10 of the Best’ showcase of projects that support improvement in human health. Her research is cited in 27 clinical guidelines and position papers on pulmonary rehabilitation, pulmonary fibrosis, COPD, skeletal muscle dysfunction, oxygen therapy & respiratory management, published by thoracic societies across the world.

Anne was the first physiotherapist to serve as a TSANZ Board Director (2016-2020). She has contributed to the advancement of thoracic medicine in Australia and New Zealand as Chair of the TSANZ Clinical Care and Resources Subcommittee, where she oversaw the development of 14 new or updated TSANZ guidelines. Anne implemented an Open Access publication policy for TSANZ documents, to ensure that policymakers, clinicians and patients have free access to information on best practice. Since 2009 Anne has been an editor for the Cochrane Airways Group, providing editorial oversight for Cochrane Reviews that define best evidence for treatment of chronic respiratory disease.

Anne has a strong commitment to development of research pathways for clinicians. She has provided research mentorship for 43 clinician-researchers over the last 15 years across many disciplines including physiotherapy, occupational therapy, nutrition, prosthetics & orthotics, nursing, exercise physiology and medicine. She has supervised 33 clinician-researchers undertaking research higher degrees. Her research program currently provides postdoctoral training opportunities for 8 clinician-researchers and regularly hosts visiting research fellows from around the world including Brazil, Norway, Denmark, Japan, Spain, the United Kingdom and Canada.

See more about Anne's respiratory care research group:

CRE-PF Town Hall Meeting

The CRE-PF held a virtual "Town Hall Meeting" on April 23, 2021 to discuss strategic directions for PF research in Australia and New Zealand. The meeting was chaired by Prof Paul Reynolds; updates on the CRE-PF were presented by A/Prof Tamera Corte followed by open discussion. 

Contact Kate Christian on for a link to view the video of the meeting.

CREATE Collaboration Grants-in-aid

Congratulations to the successful applicants for CREATE Grants-in-Aid, awarded to assist collaborative investigator-led Pulmonary Fibrosis research between CREATE Fellows from two or more institutions. 

Dr Laura Glenn and Dr Alan Teoh, Royal Prince Alfred Hospital, Dr Hayley Barnes, Alfred Health and Dr John Mackintosh, Prince Charles Hospital for development of a standard framework for ILD multi-disciplinary research meetings.

Dr Gang Liu, UTS, Dr Ashleigh Philip, Garvan Institute and Dr Laura Glenn, Royal Prince Alfred Hospital for development of a fingerprint of the proteins that are present in lung fibrosis.

Lung Foundation Australia Grants and Awards for CREATE Fellows

Congratulations to six CREATE Fellows for receipt of 2020/21 LFA grants and awards:

Dr Yet Hong Khor, LFA Research Grant in IPF supported by the Lizotte Family

Dr Gang Liu LFA, Research Grant in IPF in memory of Ivan Cash

Dr Laura Glenn, LFA PhD scholarship, supported by Di Cox

Dr Matthew Parker, LFA PhD scholarship

Ms Claudia Sim, CREATE Hope PhD scholarship

Ms Joanna Lee, CREATE Hope PhD scholarship

American Thoracic Society International Scholarship for Archana

Congratulations to CREATE Fellow and PhD student Archana Gaikwad for receiving the American Thoracic Society (ATS) International Scholarship for her work on Idiopathic Pulmonary Fibrosis, investigating the role of Endothelial to Mesenchymal Transition (EndMT) with a presentation at ATS International Scholars Colloquium. This work brings further understanding to pathogenesis of this insidious disease with opportunities for novel therapeutic targets.

Lung Health Legend Awards 2020

Congratulations to CRE-PF CIA A/Prof Tamera Corte, CREATE mentor Prof Jenny Alison and other recipients of the Lung Foundation Australia Lung Health Legend 2020 Awards.

The Board of Directors of Lung Foundation Australia has announced these virtual Lifetime Achievement Awards and the inaugural Lung Health Legends Awards for 2020 to celebrate 30 years of service. The strong partnership that exists between Lung Foundation Australia, health professionals and researchers is the bedrock of Lung Foundation Australia's success. The support of thousands of health professionals over the last 30 years has directly improved the treatment, care and support of people with lung disease and lung cancer. These awards acknowledge and recognise the individuals within our community who have made a significant contribution to lung health. Each of the award recipients demonstrate a passion and dedication to improving the lives of people impacted by lung disease or lung cancer.

CREATE Hope PhD Scholarships for Pulmonary Fibrosis Research

Thanks to a donation from Lung Foundation Australia's Hope Research Fund the CRE-PF and LFA offered two PhD scholarships for a new or ongoing student, each for $28,000 have been awarded for academic year 2021. Congratulations to to the winners of the CREATE Hope PhD scholarships: Joanna Lee (Self-management for pulmonary fibrosis: what does it mean and how might it help?) and Claudia Sim (Targeting fibrosis with relaxin – a new therapeutic strategy for IPF and silicosis), both from Monash University in Melbourne.

PACT Grant-in-aid

 In 2021, there is ONE (1) Grant-in-Aid opportunity valued at up to AUD30,000 to assist investigator led Pulmonary Fibrosis clinical research. Applications for the second annual PACT Grant-in-Aid for Investigator-led Pulmonary Fibrosis Clinical Research have now closed. The winning application will be announced at TSANZ in May.


News from 2020

CREATE Collaboration Grant 2020

Congratulations to Dr Jade Jaffar and Dr Yet Khor for their successful CREATE Collaboration Grant application announced on Friday October 16, 2020.

This Grant-in-Aid will be used to foster the collaborative efforts of Dr Jaffar and Dr Khor in establishing a multi-pronged research program on the effects of hypoxaemia (low oxygen levels) and oxygen therapy in interstitial lung disease (ILD), complex lung scarring diseases without cure. This program  crosses the basic science and clinical boundaries. This funding will specifically support the formulation of the overall collaborative experimental approaches, as well as the collection of preliminary data required for future grant applications.

Pulmonary Fibrosis Awareness Month

September was Pulmonary Fibrosis Awareness month. In an article featuring A/Prof Tamera Corte Lung Foundation Australia announced they will provide the nation’s single-biggest philanthropic investment in dedicated PF research to the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF).

The $1.1 million investment will help support ground-breaking and world-leading discoveries into PF, providing hope that has never existed before. 

  • A/Prof Tamera Corte featured in The Limbic on July 29, 2000. 

IPF Diagnosis and anti-fibrotic treatment possible without SLB


  • The July imPACT Newsletter now available. This latest newsletter includes a CRE-PF update from A/Prof Tamera Corte as well as updates from Prof Dan Chambers on PACT trials and grants.  Please have a look at what the PACT team have been up to.  The newsletter can be accessed here


  • Congratulations to Prof Daniel Chambers and his team of investigators on their successful MRFF Grant application - The TELO-SCOPE Study: Attenuating telomere attrition with Danazol. Is there scope to dramatically improve health outcomes for adults and children with pulmonary fibrosis?
    • This is an investigator-led clinical trial that will be supported by PACT and will be a welcome and much-needed addition to the limited number of Australian clinical trials undertaken in ILD.


  • Prof Daniel Chambers appeared on Sunrise in June speaking about IPF and Lung Transplant. See video link below:

Prof Daniel Chambers appears on Sunrise talking IPF, lung transplant and Lewis the wonder dog!


  • The Limbic 10 March 2020

Coronavirus: LFA advice for people living with a lung condition


News from 2019

Dr Lauren Troy who received PACT Grant-in-Aid funding for the COLDICE Study sat down with A/Prof Tamera Corte and the PACT team in "Five Minutes with a Pulmonary Fibrosis Researcher"

News from 2018

    • The Limbic 3 August 2018

    Checklists to consensus in ILD


    • Global IPF Collaborative Network July 2018

    An overview of The Centre of Research Excellence in Pulmonary Fibrosis is provided in the "Collaborator Spotlight".  Network Newsletter - July 2018


    • The Limbic 26 April 2018

    New ILD toolkit for clinicians


    • LFA award recipients announced at the 2018 TSANZ Annual Scientific Meeting

    Congratulations to Dr Helen Jo, recipient of the Lung Foundation Australia/Ivan Cash Grant in Aid for Idiopathic Pulmonary Fibrosis (IPF) Research and Dr Jade Jaffar, recipient of the Lung Foundation Australia/Lizotte Family Research Award for Idiopathic Pulmonary Fibrosis (IPF) Research.


    • The Limbic 15 March 2018

    Cochrane Review highlights lack of evidence for ILD treatment


    • The Limbic 5 February 2018

    Cautious optimism on IPF in new position statement


    News from 2017

    • Lung Foundation Australia 4 December 2017

    Promising time for Pulmonary Fibrosis patients


    • Respiratory Practice Review Issue 2, 30th November 2017

    The interstitial lung disease multidisciplinary meeting position statement

    Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand


    • MJA InSight Issue 45, November 20 2017:

    Idiopathic pulmonary fibrosis: Promise on the horizon


    • The Limbic, 30th October 2017:

    ILD benefits from multidisciplinary discussion